Down-regulation of protein kinase Cη by antisense oligonucleotides sensitises A549 lung cancer cells to vincristine and paclitaxel

Cancer Letters

Volumn 209, Issue 2, 2004, Pages 177-185

  Sonnemann, Jürgen ^a   Gekeler, Volker ^b   Ahlbrecht, Katrin ^a   Brischwein, Klaus ^a   Liu, Chao ^c   Bader, Peter ^c   Müller, Cornelia ^a   Niethammer, Dietrich ^c   Beck, James F ^a,d  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b ALTANA PHARMA AG   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d Klin und Poliklin F Kindermedizin   (Germany)

Author keywords

Antisense oligonucleotides; Bcl xL; Caspase 3; Paclitaxel; PKC ; Vincristine

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CASPASE 3; CYTOSTATIC AGENT; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE; PACLITAXEL; PROTEIN BCL XL; PROTEIN KINASE C ETA; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; VINCRISTINE;

ARTICLE; CARCINOMA CELL; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; BCL-X PROTEIN; DOWN-REGULATION; DRUG RESISTANCE, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MEMBRANE POTENTIALS; MITOCHONDRIA; OLIGONUCLEOTIDES, ANTISENSE; PACLITAXEL; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-BCL-2; RNA, MESSENGER; TUMOR CELLS, CULTURED; VINCRISTINE;

EID: 2442658767     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.02.001     Document Type: Article

References (28)

1. Ferreira C.G., Epping M., Kruyt F.A., Giaccone G. Apoptosis: target of cancer therapy. Clin. Cancer Res. 8:2002;2024-2034
2. Hengartner M.O. The biochemistry of apoptosis. Nature. 407:2000;770-776
3. Cartee L., Kucera G.L. Protein kinase C modulation and anticancer drug response. Cancer Invest. 18:2000;731-739
4. Mellor H., Parker P.J. The extended protein kinase C superfamily. Biochem. J. 332:(Pt 2):1998;281-292
5. Beck J., Bohnet B., Brugger D., Bader P., Dietl J., Scheper R.J., et al. Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers, and correlations of PKC eta with MDR1, MRP and LRP gene expression. Br. J. Cancer. 77:1998;87-91
6. Beck J.F., Bohnet B., Brugger D., Dietl J., Scheper R.J., Bader P., et al. Expression analysis of protein kinase C isozymes and multidrug resistance associated genes in ovarian cancer cells. Anticancer Res. 18:1998;701-705
7. Beck J., Handgretinger R., Klingebiel T., Dopfer R., Schaich M., Ehninger G., et al. Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML. Leukemia. 10:1996;426-433
8. Masso-Welch P.A., Winston J.S., Edge S., Darcy K.M., Asch H., Vaughan M.M., Ip M.M. Altered expression and localization of PKC eta in human breast tumors. Breast Cancer Res. Treat. 68:2001;211-223
9. Doi S., Goldstein D., Hug H., Weinstein I.B. Expression of multiple isoforms of protein kinase C in normal human colon mucosa and colon tumors and decreased levels of protein kinase C beta and eta mRNAs in the tumors. Mol. Carcinog. 11:1994;197-203
10. Ohba M., Ishino K., Kashiwagi M., Kawabe S., Chida K., Huh N.H., Kuroki T. Induction of differentiation in normal human keratinocytes by adenovirus-mediated introduction of the eta and delta isoforms of protein kinase C. Mol. Cell. Biol. 18:1998;5199-5207
11. Kashiwagi M., Ohba M., Watanabe H., Ishino K., Kasahara K., Sanai Y., et al. PKCeta associates with cyclin E/cdk2/p21 complex, phosphorylates p21 and inhibits cdk2 kinase in keratinocytes. Oncogene. 19:2000;6334-6341
12. Basu A. The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha. Mol. Pharmacol. 53:1998;105-111
13. Akkaraju G.R., Basu A. Overexpression of protein kinase C-eta attenuates caspase activation and tumor necrosis factor-alpha-induced cell death. Biochem. Biophys. Res. Commun. 279:2000;103-107
14. Hussaini I.M., Karns L.R., Vinton G., Carpenter J.E., Redpath G.T., Sando J.J., Vandenberg S.R. Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific proliferative response in astrocytic tumor cells. J. Biol. Chem. 275:2000;22348-22354
15. Hussaini I.M., Carpenter J.E., Redpath G.T., Sando J.J., Shaffrey M.E., Vandenberg S.R. Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation. Neurooncology. 4:2002;9-21
16. Matsumura M., Tanaka N., Kuroki T., Ichihashi M., Ohba M. The eta isoform of protein kinase C inhibits UV-induced activation of caspase-3 in normal human keratinocytes. Biochem. Biophys. Res. Commun. 303:2003;350-356
17. Schonwasser D.C., Marais R.M., Marshall C.J., Parker P.J. Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol. Cell. Biol. 18:1998;790-798
18. Weinstein-Oppenheimer C.R., Henriquez-Roldan C.F., Davis J.M., Navolanic P.M., Saleh O.A., Steelman L.S., et al. Role of the Raf signal transduction cascade in the in vitro resistance to the anticancer drug doxorubicin. Clin. Cancer Res. 7:2001;2898-2907
19. Metivier D., Dallaporta B., Zamzami N., Larochette N., Susin S.A., Marzo I., Kroemer G. Cytofluorometric detection of mitochondrial alterations in early CD95/Fas/APO-1-triggered apoptosis of Jurkat T lymphoma cells. Comparison of seven mitochondrion-specific fluorochromes. Immunol. Lett. 61:1998;157-163
20. Dias N., Stein C.A. Antisense oligonucleotides: basic concepts and mechanisms. Mol. Cancer Ther. 1:2002;347-355
21. Monia B.P., Lesnik E.A., Gonzalez C., Lima W.F., McGee D., Guinosso C.J., et al. Evaluation of 2′-modified oligonucleotides containing 2′-deoxy gaps as antisense inhibitors of gene expression. J. Biol. Chem. 268:1993;14514-14522
22. Sternberger M., Schmiedeknecht A., Kretschmer A., Gebhardt F., Leenders F., Czauderna F., et al. GeneBlocs are powerful tools to study and delineate signal transduction processes that regulate cell growth and transformation. Antisense Nucleic Acid Drug Dev. 12:2002;131-143
23. Taylor J.K., Zhang Q.Q., Monia B.P., Marcusson E.G., Dean N.M. Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuli. Oncogene. 18:1999;4495-4504
24. Thornberry N.A., Lazebnik Y. Caspases: enemies within. Science. 281:1998;1312-1316
25. Lowe S.W., Ruley H.E., Jacks T., Housman D.E. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell. 74:1993;957-967
26. Ackermann E.J., Taylor J.K., Narayana R., Bennett C.F. The role of antiapoptotic Bcl-2 family members in endothelial apoptosis elucidated with antisense oligonucleotides. J. Biol. Chem. 274:1999;11245-11252
27. Lebedeva I., Rando R., Ojwang J., Cossum P., Stein C.A. Bcl-xL in prostate cancer cells: effects of overexpression and down-regulation on chemosensitivity. Cancer Res. 60:2000;6052-6060
28. Hinz S., Trauzold A., Boenicke L., Sandberg C., Beckmann S., Bayer E., et al. Bcl-xL protects pancreatic adenocarcinoma cells against CD95- and TRAIL-receptor-mediated apoptosis. Oncogene. 19:2000;5477-5486